Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology
Week-long Fire Safety Week 2026 campaign focuses on strengthening fire prevention, preparedness, audits, and emergency response across hospitals and healthcare facilities
The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
Two-day long National Health Summit highlighted progress under the NHM and called for data-driven and SDG-aligned health system reforms
Strong CDMO growth, improved product mix and operational leverage drive profitability expansion
Health innovations are viewed more positively than food and agricultural technologies
Union health minister urges graduates in Chandigarh to combine technological excellence with compassion in medical practice
Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
Subscribe To Our Newsletter & Stay Updated
